Search Results - "Hallek, M.J"

Second interim analysis of a phase 3 study evaluating idelalisib and rituximab for relapsed chronic lymphocytic leukemia by Ghia, P, Coutre, S.E, Furman, R.R, Sharman, J.P, Cheson, B.D, Pagel, J.M, Hillmen, P, Barrientos, J.C, Zelenetz, A.D, Kipps, T.J, Flinn, I.W, Eradat, H.A, Lamanna, N, Coiffier, B, Pettitt, A, Li, X, Jahn, T.M, O'Brien, S.M, Hallek, M.J

Get full text

4.25 Update on the International Standardized Approach for Flow Cytometric Residual Disease Monitoring in CLL by Rawstron, A.C, Böttcher, S, Letestu, R, Villamor, N, Fazi, C, Kartsios, H, de Tute, R, Shingles, J, Ritgen, M, Moreno, C, Kneba, M, Montserrat, E, Cymbalista, F, Hallek, M.J, Hillmen, P, Ghia, P

Get full text

Advances in chemotherapy for chronic lymphocytic leukemia by Wendtner, C.-M, Eichhorst, B.F, Hallek, M.J

“…While chemotherapy based on alkylating agents has been the standard treatment of chronic lymphocytic leukemia (CLL) for decades, purine analogues and their…”
Get full text

1521P Addition of durvalumab to CROSS in oesophageal adenocarcinoma is feasible and safe by Schloesser, H., Lohneis, A., Garcia-Marquez, M.A., Thelen, M., Schiller, P., von Bergwelt, M., Hillmer, A., Schroeder, W., Hallek, M.J., Quaas, A., Bruns, C., Zander, T.

Get full text

253P Digital decision support for structural improvement of lung cancer tumor boards: Using standard cases to optimize workflow by Gross-Ophoff-Mueller, C., Hoier, D., Oden, A., Hallek, M.J., Greeske, A., Heidelbach, J., Elter, T.

Get full text

Changing paradigms in the treatment of chronic lymphocytic leukemia by Foon, K A, Hallek, M J

“…Progress in our understanding of chronic lymphocytic leukemia and its treatment has resulted in a more tailored approach to patient management, with different…”
Get full text

International Standardized Approach to Molecular and Flow Cytometric Residual Disease Monitoring in CLL by Rawstron, A.C., Villamor, N., Zehnder, J.L., Ghia, P., Ritgen, M., Bottcher, S., Lozanski, G., Mone, A.P., Colomer, D., Moreno, C., Geuna, M., Evans, P.A., Kneba, M., Natkunam, Y., Coutre, S.E., Caligaris-Cappio, F., Hallek, M.J., Byrd, J.C., Montserrat, E., Hillmen, P.

“…Conventional therapy in CLL is not curative, partly because minimal residual disease (MRD) is usually detectable after therapy. Recent therapeutic approaches…”
Get full text

Transplantation hämatopoetischer Stammzellen: Knochenmark und Blutstammzellen by von Bergwelt-Baildon, M., Holtick, U., Hallek, M.J., Scheid, C.

“…Zusammenfassung Die Zahl der Stammzelltransplantationen in Deutschland nimmt seit Jahren stetig zu. Patienten mit höherem Lebensalter und umfassenden…”
Get full text